$IMAX

Nomura entities disclose 5.4% IMAX (IMAX) stake totaling 2.94M shares

Nomura Asset Management International Inc. and Nomura Investment Management Business Trust filed an amended Schedule 13G/A for IMAX Corp. They report beneficial ownership of 2,936,661 IMAX common shares, about 5.4% of 54,842,114 shares outstanding as of June 30, 2026, with shared voting and dispositive power.

Original reporting
Published Aug 14, 2026, 5:54 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2026, 9:37 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$IMAX
Neutral
medium confidence
Mentioned
$IMAX
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$IMAXNeutralLow
01

Why it matters

The disclosure increases transparency about a significant shareholder position but provides no evidence of control, board influence, or a near-term corporate catalyst.

02

Market read

Traders get a fresh, primary-source update on a 5.4% beneficial ownership stake in IMAX, but without accompanying strategic or operational developments.

03

What to watch

The filing notes exclusion of certain Nomura Holdings Inc. subsidiary holdings, so the true consolidated exposure may differ from the reported stake.

Relevance 4/10Novelty 4/10Timing: filing disclosed on 2026-08-14 (Schedule 13G/A update)

Background

The article summarizes an amended Schedule 13G/A where Nomura Asset Management International Inc. and Nomura Investment Management Business Trust report beneficial ownership in IMAX.

Company-level read

Ticker impact

$IMAXNeutralMedium confidence
Context

Nomura entities filed an amended Schedule 13G/A disclosing a 5.4% beneficial stake in IMAX totaling 2,936,661 shares.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven around ownership concentration rather than fundamentals.

Evidence & confidence

The article only reports beneficial ownership and percentage of class based on IMAX shares outstanding, with no accompanying strategic action, governance demand, or transaction details.

Market effects

Minimal, since the disclosure is company-specific ownership without sector-wide signal.

None indicated; Nomura entities are global asset managers but no regional policy or demand shift is described.

Low; the filing is a transparency update rather than a cross-border deal or regulatory action.

Counterpoint

A 5.4% stake could be a precursor to further accumulation or engagement, so traders may watch for follow-on 13D/13G amendments or governance actions.

Key entities

  • IMAX CORP

    Beneficiary of the disclosed 5.4% stake by Nomura entities via amended Schedule 13G/A.

  • Nomura Asset Management International Inc.

    Reporting person for beneficial ownership of 2,936,661 IMAX shares with shared voting and dispositive power.

  • Nomura Investment Management Business Trust

    Co-reporting person for the same beneficial ownership position in IMAX.

Related articles

$IMAXMed

Why IMAX Stock Climbed to a New All-Time High Today

IMAX stock reached a new all-time high on Monday, rising 3.89% to $54.79. The surge was driven by the record-breaking success of The Odyssey, which became the highest-grossing IMAX release. CEO Rich Gelfond expects this to be their best year. Analyst Steve Frankel predicts IMAX will exceed estimates in the second half of 2026, with shares potentially rising to $60. The company's Q2 2026 revenue grew 12% to $103 million, with adjusted earnings up 65% to $0.43 per share.

$IMAXMed

“The Odyssey” Demand Drives IMAX Shares Higher

IMAX reported Q2 2026 revenue of $103M (up 12% YoY) and EPS of $0.43 (up 65%), driven by strong demand for 'The Odyssey'. The stock has gained 42% YTD, with institutional inflows contributing to a 103.5% rise over the past year. IMAX shows strong sales and EPS growth rates of 11.7% and 18.7% respectively over three years, with EPS expected to rise 14% this year.

$IMAXMed

Why IMAX Stock Rallied on Monday

IMAX shares rose about 5% on Monday after the company said Christopher Nolan’s film The Odyssey became the highest-grossing IMAX release of all time. IMAX reported $289 million in ticket sales, plus $37 million in the fourth weekend, and said IMAX theaters account for 26% of total tickets. IMAX added that 70mm locations have grossed over $37 million and presales near $40 million.

$IMAXMed

Why IMAX Stock Soared on Monday

IMAX said The Odyssey helped it post its highest-ever monthly box-office results, with July box-office revenue of $257 million, up 47% from the prior record. Ticket sales for The Odyssey totaled $221 million. IMAX also announced an upcoming run for Spider-Man: Brand New Day and shares closed Monday nearly 7% higher.

$IMAXMed

'The Odyssey' fuels Imax stock to all-time high. CEO calls momentum a 'flywheel'

Imax shares hit an all-time high Monday, up nearly 6%, after box office momentum from Christopher Nolan’s “The Odyssey.” The company said the film is tracking almost double “Oppenheimer” (2023) and generated $221 million globally, about 25% of Universal’s total. CEO Rich Gelfond attributed results to a “flywheel” of theater expansion and recurring cash flow.